Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
700
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cytek BioSciences Inc market cap is $800.4M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cytek BioSciences Inc 52 week high is $6.39 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cytek BioSciences Inc 52 week low is $3.31 as of November 22, 2026.
Cytek BioSciences Inc stock price today is $6.12.
Cytek BioSciences Inc stock price yesterday was $6.32.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cytek BioSciences Inc's P/E ratio is -9.7.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cytek BioSciences Inc P/B ratio is 2.4905.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cytek BioSciences Inc 50-day moving average is $5.63.